Journal Health of Woman. 2024. 6(175): 32-36. doi: 10.15574/HW.2024.6(175).3236

Kupchik L. M., Kupchik V. I.
Bogomolets National Medical University, Kyiv, Ukraine

For citation: Kupchik LM, Kupchik VI. (2024). Clinical and laboratory peculiarities of pregnancy course complicated with gestational diabetes mellitus and exocrine pancreatic insufficiency. Ukrainian Journal Health of Woman. 6(175): 32-36. doi: 10.15574/HW.2024.6(175).3236
Article received: Sep 06, 2024. Accepted for publication: Nov 27, 2024.

The course of pregnancy can be accompanied by a number of adverse conditions, one of which is gestational diabetes mellitus (GDM). Reduced glucose tolerance is an adaptive mechanism during pregnancy, but the development of GDM is based on a certain decompensation of pancreatic functions, which may affect not only endocrine but also exocrine pancreatic activity (EPA).
Aim – to study the anamnestic, clinical and laboratory features of the course of pregnancy with reduced EPA in GDM.
Materials and methods. The study involved 112 patients (87 women from the main group, divided into 2 subgroups according to the presence of dyspeptic symptoms; and 25 pregnant women from the control group). Anamnestic data, the course of this pregnancy were studied and enzyme immunoassays for serum trypsinogen (TPG) and fecal elastase-1 (FE-1) concentrations were performed. Statistical analysis conducted using Microsoft Office Excel and MedStat software. The difference between groups was considered significant at p≤0.05.
Results. In pregnant women with GDM and reduced EPA, the presence of factors in the anamnesis that potentially affect the development of pancreatic diseases was established. Significantly lower TPG and FE-1 levels were found in the main group compared to the control group. A direct relationship was determined between the degree of reduction in EPA in GDM and clinical manifestations of dyspepsia, as well as with the occurrence of early pregnancy complications.
Conclusions. Increasing maternal age, previous gastrointestinal diseases, polycystic ovary syndrome, and obesity are associated with a greater severity of decreased EPA in women with GDM, clinically manifested by the occurrence of dyspeptic manifestations, vomiting of pregnancy, and threatened abortion; laboratory findings were: decreased TPG and FE-1 concentrations, which correlate with the severity of clinical picture.
The study was conducted in accordance with principles of the Declaration of Helsinki. Research protocol was approved by local ethics committee of the participating institution. Informed consent was obtained.
The authors declare no conflict of interest.
Keywords: gestational diabetes mellitus, pregnancy, exocrine pancreatic insufficiency, pancreatic enzymes, fecal elastase-1, trypsinogen.

REFERENCES

1. Barbetti F, Deeb A, Suzuki S. (2024). Neonatal diabetes mellitus around the world: Update 2024. Journal of Diabetes Investigation. 15(12): 1711-1724. https://doi.org/10.1111/jdi.14312; PMid:39344692 PMCid:PMC11615689

2. Kautzky-Willer A, Winhofer Y, Kiss H, Falcone V, Berger A, Lechleitner M et al. (2023). Gestational diabetes mellitus (Update 2023). Wiener klinische Wochenschrift. 135(S1): 115-128. https://doi.org/10.1007/s00508-023-02181-9; PMid:37101032 PMCid:PMC10132924

3. Khara МR, Korda IV, Podilska TI. (2023). Gestational diabetus mellitus and its complications, role of desynchronosis in pathogenesis (a review). Pathologia. 20(2): 195-202. https://doi.org/10.14739/2310-1237.2023.2.282626

4. Kunovský L, Dítě P, Jabandžiev P, Eid M, Poredská K, Vaculová J et al. (2021). Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis. Journal of Clinical Medicine. 10(24): 5779. https://doi.org/10.3390/jcm10245779; PMid:34945075 PMCid:PMC8708123

5. Lee HJ, Norwitz E, Lee B. (2018). Relationship between threatened miscarriage and gestational diabetes mellitus. BMC Pregnancy and Childbirth, 18(1). https://doi.org/10.1186/s12884-018-1955-2; PMid:30081861 PMCid:PMC6080503

6. Lembryk IS, Tymoshchuk OV. (2020). Exocrine pancreatic dysfunction in children with obesity: characteristics of clinical picture and diagnostics. Likarska sprava, (1-2): 36-41. https://doi.org/10.31640/JVD.1-2.2020(5)

7. Malin SK, Kirwan JP, Sia CL, González F. (2015). Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation. American Journal of Physiology-Endocrinology and Metabolism. 308(9): E770-E777. https://doi.org/10.1152/ajpendo.00510.2014; PMid:25714674 PMCid:PMC4420895

8. Nteeba J, Kubota K, Wang W, Zhu H, Vivian JL et al. (2019). Pancreatic prolactin receptor signaling regulates maternal glucose homeostasis. Journal of Endocrinology. 241(1): 71-83. https://doi.org/10.1530/JOE-18-0518; PMid:30798322 PMCid:PMC7189340

9. Olmos JI, Piskorz MM, Litwin N, Schaab S, Tevez A, Bravo-Velez G et al. (2022). Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria. Digestive Diseases and Sciences. 67(12): 5666-5675. Epub 2022 Jun 15. https://doi.org/10.1007/s10620-022-07568-8; PMid:35704255

10. Pfister E, Dröge C, Liebe R, Stalke A, Buhl N, Ballauff A et al. (2022). Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: Presentation of a case series and literature review. Liver International. 42(5): 1084-1096. Epub 2022 Mar 15. https://doi.org/10.1111/liv.15200; PMid:35184362

11. Phillips AE, Bejjani J, Culp S, Chennat J, Lee PJ, Machicado JD et al. (2024). Prevalence of exocrine pancreatic insufficiency at 12 months after acute pancreatitis: a prospective, multicentre, longitudinal cohort study. eClinicalMedicine. 75: 102774. https://doi.org/10.1016/j.eclinm.2024.102774; PMid:39210941 PMCid:PMC11359981

12. Sheiner E. (2020). Gestational Diabetes Mellitus: Long-Term Consequences for the Mother and Child Grand Challenge: How to Move on Towards Secondary Prevention? Frontiers in Clinical Diabetes and Healthcare. 1. https://doi.org/10.3389/fcdhc.2020.546256; PMid:36993989 PMCid:PMC10041873

13. Singh A, Singh RK, Singh AK, Chauhan M, Gautam V. (2023). Evaluation of Serum Amylase and Lipase in Gestational Diabetes Mellitus and Association With Gastrointestinal Symptoms. Cureus. 5(11): e48376. PMID: 38060711; PMCID: PMC10698305. https://doi.org/10.7759/cureus.48376

14. Tang M, Xu J-M, Song S-S, Mei Q, Zhang L-J. (2018). What may cause fetus loss from acute pancreatitis in pregnancy. Medicine. 97(7): e9755. https://doi.org/10.1097/MD.0000000000009755; PMid:29443736 PMCid:PMC5839860

15. Wu D, Ru N, Wang Y-C, Ma G-X, Shi T-Y, Xiong S-H et al. (2024). Genetic Factors Associated with Adverse Pregnancy Outcomes in Chronic Pancreatitis. Clinical and Translational Gastroenterology. 15(4): e00691. https://doi.org/10.14309/ctg.0000000000000691; PMid:38334943 PMCid:PMC11042769

16. Zhan W, Akshintala V, Greer PJ, Greer JB, Alkaade S, Anderson MA et al. (2020). Low serum trypsinogen levels in chronic pancreatitis: Correlation with parenchymal loss, exocrine pancreatic insufficiency, and diabetes but not CT-based cambridge severity scores for fibrosis. Pancreatology. 20(7): 1368-1378. https://doi.org/10.1016/j.pan.2020.08.025; PMid:32967795